Research ArticleOther Arthritides
Open Access
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R. Curtis, Xiaofeng Zhou, David T. Rubin, Walter Reinisch, Jinoos Yazdany, Philip C. Robinson, Yan Chen, Birgitta Benda, Ann Madsen and Jamie Geier
The Journal of Rheumatology March 2022, 49 (3) 320-329; DOI: https://doi.org/10.3899/jrheum.210888
Jeffrey R. Curtis
1J.R. Curtis, MD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA;
Xiaofeng Zhou
2X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA;
David T. Rubin
3D.T. Rubin, MD, University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA;
Walter Reinisch
4W. Reinisch, MD, Medical University of Vienna, Vienna, Austria;
Jinoos Yazdany
5J. Yazdany, MD, Division of Rheumatology, Department of Medicine, University of California, San Francisco, California, USA;
Philip C. Robinson
6P.C. Robinson, MBChB, PhD, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
Yan Chen
2X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA;
Birgitta Benda
2X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA;
Ann Madsen
2X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA;
Jamie Geier
2X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA;
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Wallace PJ,
- Shah ND,
- Dennen T,
- Bleicher PA,
- Crown WH.
- 6.↵
- Strangfeld A,
- Schäfer M,
- Gianfrancesco MA, et al; COVID-19 Global Rheumatology Alliance
- 7.↵
- Gianfrancesco M,
- Hyrich KL,
- Al-Adely S, et al; COVID-19 Global Rheumatology Alliance
- 8.↵
- 9.↵
- D’Silva KM,
- Serling-Boyd N,
- Wallwork R, et al.
- 10.↵
- Pablos JL,
- Galindo M,
- Carmona L, et al; RIER Investigators Group
- 11.↵
- Topless RK,
- Phipps-Green A,
- Leask M, et al.
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- Sparks JA,
- Wallace ZS,
- Seet AM, et al; COVID-19 Global Rheumatology Alliance
- 16.↵
- 17.↵
- Kluberg S.
- 18.↵
- Kim TS,
- Roslin M,
- Wang JJ,
- Kane J,
- Hirsch JS,
- Kim EJ; Northwell Health COVID-19 Research Consortium
In this issue
The Journal of Rheumatology
Vol. 49, Issue 3
1 Mar 2022
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R. Curtis, Xiaofeng Zhou, David T. Rubin, Walter Reinisch, Jinoos Yazdany, Philip C. Robinson, Yan Chen, Birgitta Benda, Ann Madsen, Jamie Geier
The Journal of Rheumatology Mar 2022, 49 (3) 320-329; DOI: 10.3899/jrheum.210888
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
Jeffrey R. Curtis, Xiaofeng Zhou, David T. Rubin, Walter Reinisch, Jinoos Yazdany, Philip C. Robinson, Yan Chen, Birgitta Benda, Ann Madsen, Jamie Geier
The Journal of Rheumatology Mar 2022, 49 (3) 320-329; DOI: 10.3899/jrheum.210888